Alefacept in the treatment of psoriatic nail disease: a proof of concept study.
Nail psoriasis can be debilitating and as therapeutic options are limited, it can be notoriously difficult to treat. As there are many new medications currently undergoing clinical trials in psoriasis, questions have arisen concerning the effectiveness of these new therapies with regard to psoriatic nail disease. We present the results of a prospective, open-label, proof of concept study to determine the efficacy and safety of alefacept in subjects with moderate to severe nail psoriasis.
Parrish
Charles A
CA
Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Sobera
Jenny O
JO
Robbins
Courtney M
CM
Cantrell
Wendy C
WC
Desmond
Renee A
RA
Elewski
Boni E
BE